Paritosh Garg: From Replacing Platelets to Stimulating Platelet Production
Paritosh Garg, Associate Consultant at Fortis Memorial Research Institute, India, shared a post on LinkedIn about a recent article by Raoel Maan et al., published in Drugs, adding:
“Thrombocytopenia in chronic liver disease is not just a platelet-count problem.
It influences procedural planning, antiviral therapy, transfusion decisions, and thrombotic risk assessment.
This review highlights an important shift in supportive care:
From replacing platelets to stimulating platelet production.
Thrombopoietin receptor agonists opened a new therapeutic space, but the key message remains clinical judgment.
In CLD, the question is not only:
‘Can we increase the platelet count?’
It is also:
‘At what thrombotic cost, and in which patient?’
A practical reminder that supportive care in hematology is never ‘supportive only’ — it often determines whether definitive care can safely proceed.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering